Home » FDA Approves Two Ortho Hepatitis B Assays
FDA Approves Two Ortho Hepatitis B Assays
Ortho Clinical Diagnostics received FDA approval for its Vitros HBeAg and Anti-HBe assays for use with the company’s Vitros 5600 and 3600 systems.
Both assays are currently available on the Vitros ECi/ECiQ immunodiagnostic systems.
The assays are used to diagnose individuals with acute or chronic hepatitis B or in recovery from hepatitis B infection.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May